# Surgery, Gemcitabine, Cisplatin, and Radiation Therapy in Treating Patients With Stage II or Stage III Non-Small Cell Lung Cancer

> **NCT00530634** · PHASE2 · TERMINATED · sponsor: **City of Hope Medical Center** · enrollment: 3 (actual)

## Conditions studied

- Lung Cancer

## Interventions

- **DRUG:** cisplatin
- **DRUG:** gemcitabine hydrochloride
- **GENETIC:** gene expression analysis
- **GENETIC:** reverse transcriptase-polymerase chain reaction
- **OTHER:** immunohistochemistry staining method
- **PROCEDURE:** adjuvant therapy
- **PROCEDURE:** conventional surgery
- **RADIATION:** radiation therapy

## Key facts

- **NCT ID:** NCT00530634
- **Lead sponsor:** City of Hope Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 1999-08
- **Primary completion:** 2013-06
- **Final completion:** 2013-06
- **Target enrollment:** 3 (ACTUAL)
- **Why stopped:** Poor accrual
- **Last updated:** 2015-10-29

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00530634

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00530634, "Surgery, Gemcitabine, Cisplatin, and Radiation Therapy in Treating Patients With Stage II or Stage III Non-Small Cell Lung Cancer". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT00530634. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*